T1	Participants 274 381	Twenty drug-free adults with autistic disorder (16 men and 4 women) (mean [+/- SD] age, 30.5 +/- 8.5 years)
T2	Participants 887 947	Eleven (65%) of the 17 patients who completed both test days
T3	Participants 1063 1123	17 patients showed any significant change in clinical status
